SeaCrest Wealth Management LLC purchased a new position in shares of Fresenius Medical Care AG & Co. (NYSE:FMS) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 2,920 shares of the company’s stock, valued at approximately $153,000.

Several other large investors have also recently added to or reduced their stakes in the company. Aperio Group LLC boosted its holdings in Fresenius Medical Care AG & Co. by 3.9% in the fourth quarter. Aperio Group LLC now owns 219,140 shares of the company’s stock valued at $11,516,000 after acquiring an additional 8,210 shares during the last quarter. Comerica Bank boosted its holdings in Fresenius Medical Care AG & Co. by 2.4% in the fourth quarter. Comerica Bank now owns 48,984 shares of the company’s stock valued at $2,769,000 after acquiring an additional 1,136 shares during the last quarter. HL Financial Services LLC bought a new stake in Fresenius Medical Care AG & Co. in the fourth quarter valued at approximately $215,000. Dean Capital Investments Management LLC bought a new stake in Fresenius Medical Care AG & Co. in the fourth quarter valued at approximately $259,000. Finally, Ferguson Wellman Capital Management Inc. boosted its holdings in Fresenius Medical Care AG & Co. by 0.7% in the fourth quarter. Ferguson Wellman Capital Management Inc. now owns 141,236 shares of the company’s stock valued at $7,422,000 after acquiring an additional 1,020 shares during the last quarter. Institutional investors own 2.57% of the company’s stock.

Fresenius Medical Care AG & Co. (NYSE FMS) opened at $54.04 on Thursday. Fresenius Medical Care AG & Co. has a 12 month low of $40.21 and a 12 month high of $57.94. The company has a quick ratio of 0.98, a current ratio of 1.22 and a debt-to-equity ratio of 0.55. The stock has a market capitalization of $32,293.91, a P/E ratio of 24.23, a price-to-earnings-growth ratio of 2.00 and a beta of 0.52.

Several analysts recently commented on FMS shares. Zacks Investment Research cut Fresenius Medical Care AG & Co. from a “buy” rating to a “sell” rating in a report on Wednesday, October 25th. Nord/LB reissued a “buy” rating on shares of Fresenius Medical Care AG & Co. in a research note on Tuesday, January 2nd. DZ Bank reissued a “buy” rating on shares of Fresenius Medical Care AG & Co. in a research note on Monday, December 18th. Morgan Stanley lowered Fresenius Medical Care AG & Co. from an “overweight” rating to an “equal weight” rating in a research note on Monday, December 11th. Finally, UBS Group raised Fresenius Medical Care AG & Co. from a “sell” rating to a “neutral” rating in a research note on Thursday, January 4th. Six investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $56.00.

COPYRIGHT VIOLATION WARNING: “SeaCrest Wealth Management LLC Purchases Shares of 2,920 Fresenius Medical Care AG & Co. (FMS)” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another publication, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2018/02/15/seacrest-wealth-management-llc-purchases-shares-of-2920-fresenius-medical-care-ag-co-fms.html.

Fresenius Medical Care AG & Co. Company Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Institutional Ownership by Quarter for Fresenius Medical Care AG & Co. (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.